製品名:3-(2-bromo-7-oxo-4,5-dihydrothieno[2,3-c]pyridin-6-yl)piperidine-2,6-dione

IUPAC Name:3-{2-bromo-7-oxo-4H,5H,6H,7H-thieno[2,3-c]pyridin-6-yl}piperidine-2,6-dione

CAS番号:2970213-45-5
分子式:C12H11BrN2O3S
純度:97%
カタログ番号:CM1076101
分子量:343.2

包装単位 有効在庫 価格(USD) 数量
CM1076101-100mg in stock ƱȦƻ
CM1076101-250mg in stock ƋƱȦ
CM1076101-500mg in stock ɅƱƋƱ
CM1076101-1g in stock ǧƙƋƙ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2970213-45-5
分子式:C12H11BrN2O3S
融点:-
SMILESコード:BrC1=CC2=C(S1)C(=O)N(CC2)C1CCC(=O)NC1=O
密度:
カタログ番号:CM1076101
分子量:343.2
沸点:
MDL番号:
保管方法:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products